Antidiabetic effects of Eucalyptus globulus on pancreatic islets: a stereological study by Mahmoudzadeh-Sagheb, H. et al.
Folia Morphol.
 Vol. 69, No. 2, pp. 112–118
Copyright © 2010 Via Medica
ISSN 0015–5659
www.fm.viamedica.pl
O R I G I N A L    A R T I C L E
112
Address for correspondence: Dr. Zahra Heidari, PhD, Department of Histology, School of Medicine, Zahedan University of Medical Sciences,
Zahedan, Iran, tel: +98 541 341 45 72, +98 915 141 42 92, fax: +98541 341 45 61, e-mail: histology@ymail.com
Antidiabetic effects of Eucalyptus globulus on
pancreatic islets: a stereological study
H. Mahmoudzadeh-Sagheb1, Z. Heidari1, M. Bokaeian2, B. Moudi3
1Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
2Department of Laboratory Sciences, School of Paramedicine, Zahedan University of Medical Sciences,
Zahedan, Iran
3Cell and Molecular Research Centre, Zahedan University of Medical Sciences, Zahan, Iran
[Received 15 March 2010; Accepted 13 April 2010]
The leaves of Eucalyptus globulus (eucalyptus) are used for the treatment of
diabetes mellitus in traditional medicine. The aim of this study was to evaluate
the effects of eucalyptus on streptozotocin (STZ)-induced damage in pancrea-
tic islands by stereological methods. Fifty mature normoglycaemic male Wistar
rats, weighing 200–250 g, were selected and randomly divided into 5 groups
(n = 10): control; STZ-induced diabetic (D) — by intraperitoneal injection of
60 mg/kg streptozotocin; treated control (TC); and treated diabetic (TD1, 2),
respectively, received 20 and 62.5 g/kg of eucalyptus in their diet, and 2.5 g/L
aqueous extract of eucalyptus in their drinking water from one week after
induction of diabetes. After four weeks of the experiment, stereological esti-
mation of volume density and total volume of islets and beta cells, volume-
-weighted mean islet volume, mass of the islets and pancreas, and total num-
ber of islets were carried out. Administration of eucalyptus significantly de-
creased the weight loss and increase of water and food intake in the treated
diabetic groups in comparison to the STZ-induced diabetic (D) group. Volume
density and total volume of islets, volume-weighted mean islet volume, mass
of islets, and mass of pancreas of both treated diabetic groups were higher
than the D group. In TD2, these stereological parameters increased significant-
ly compared to the D group (p < 0.001). Volume density and total volume of
beta cells increased 21% and 65%, respectively, in the TD2 group, but it was
not statistically significant compared to the diabetic group (p > 0.05).
The results suggested that Eucalyptus globulus with a dose-dependent man-
ner ameliorates diabetic states by partial restoration of pancreatic beta cells
and repair of STZ-induced damage in rats. This study suggests a beneficial
effect of eucalyptus in the treatment of diabetes. (Folia Morphol 2010; 69, 2:
112–118)
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INTRODUCTION
Diabetes mellitus is a chronic metabolic disorder
characterized by hyperglycaemia. It may be due to
a decrease in the synthesis of insulin (Type-I diabe-
tes) or due to a decrease in the secretion of insulin
from beta-cells of islets of the pancreas (Type-II dia-
betes) [25]. The increased glucose level generates
glucose auto oxidation and auto oxidative glycosy-
lation of proteins, which leads to oxidative stress by
increasing the reactive oxygen species [24]. Diabe-
tes mellitus produces various dysfunctions in the
body, including vascular disorder, retinopathy, car-
diomyopathy, altered immune functions, changes
in the intestinal function, peripheral neuropathy, and
dysfunction of the central nervous system [25]. Dia-
betes treatment is essential for preventing or at least
delaying the onset of these complications [29]. For
many years, a diet rich in vegetables and fruit has
been recognized as protecting against chronic dis-
eases such as diabetes. It seems that treatment with
herbal drugs can protect pancreatic beta-cells and
reduce fluctuations in glucose levels [17]. Although
present therapy for diabetes mellitus relies on an
arsenal of drugs, diabetes therapy also revolves
around dietary measures including the use of tradi-
tional antihyperglycaemic plants [1, 19, 22, 28] such
as Eucalyptus globulus. Eucalyptus globulus Labill
(Myrtaceae) is a fast-growing, evergreen tree, na-
tive to Tasmania and south-eastern Australia. It
grows best in Mediterranean climates (cool, wet
winters and dry, warm summers). It was first grown
in Iran about half century ago, and the plantation
of many of such species in the north and south had
very satisfactory results [23]. It is widely distributed
throughout the Sistan and Baluchestan provinces.
The trees flower and the fruits ripen throughout the
year. It grows in dense monocultures. Juvenile leaves
are about 6 to 15cm long and are covered with
a blue-grey, waxy bloom. The mature leaves are nar-
row, sickle-shaped, and dark shining green and
range from 15 to 35cm in length. The flower clus-
ters develop within an envelope formed by two
bracteoles which split and are shed, exposing the
flower buds. The fruit is a woody capsule 6–25 mm
in diameter. Numerous small seeds (3–6) are shed
through valves which open on the top of the fruit. It
produces roots throughout the soil profile, rooting
several feet deep in some soils [23]. Eucalyptus glob-
ulus is traditionally used to treat diabetes in South
America, Africa [7], and Iran [8]. Its medicinal uses
are as an antiseptic and deodorant, to treat hoarse-
ness, coughs, whooping coughs, asthma and bron-
chitis, coryza, dysentery, diabetes, fevers and colds,
malaria, rhinitis, and tuberculosis, and for washing
and cleaning wounds [7]. Leaves from Eucalyptus
globulus are reported to contain a high content of
eucalyptol (cineol) together with rutin, terpineol,
sesquiterpene, alcohols, aliphatic aldehydes, isoamyl
alcohol, ethanol, terpenes, and tannins [7, 8]. A study
in streptozotocin (STZ)-diabetic mice confirmed the
antihyperglycaemic effectiveness of Eucalyptus glob-
ulus. The possibility exists that dietary administra-
tion of eucalyptus was associated with the protec-
tion or regeneration of pancreatic beta-cells as in-
sulin producing cells of islets following STZ-induced
diabetes [9]. The available literature presents no data
relating to the effect of a Eucalyptus globulus sup-
plemented diet and drinking water on quantitative
parameters of pancreatic islets in STZ-induced dia-
betic rats. Therefore, in this study the effects of Eu-
calyptus globulus on pancreatic islets and beta cells
in STZ-induced diabetic rats were investigated by
stereological methods.
MATERIAL AND METHODS
Plant material
Eucalyptus globulus Labill leaves were collected
fresh from a garden in Zahedan University of Medi-
cal Sciences (ZUMS). The plant was identified and
verified at the Herbarium of Botany Directorate in
Sistan and Baluchestan University, Zahedan, Iran.
A voucher specimen was deposited in the Botany De-
partment of Sistan and Baluchestan University.
Preparation of eucalyptus-incorporated diet
and aqueous extract of Eucalyptus globulus
The leaves were homogenized to a fine powder
and stored at room temperature (20 ± 2°C) until
use. For the animals, eucalyptus was incorporated
into a powdered diet, thoroughly mixed, distilled
water was added, and it was mixed into a stiff paste.
The mixture was then pelleted and dried at 45°C.
The control diet was prepared by the same method
to ensure there were no end differences in vitamin
and mineral content due to the drying process [9].
Aqueous extract of eucalyptus (AEE) was pre-
pared by 15 minutes decoction of the powdered
material, as described by Gray and Flatt [9].
Animals
The study was performed on 50 matured nor-
moglycaemic male albino rats (Rattus norvegicus)
of Wistar strain (ZUMS animal lab, Zahedan, Iran),
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weighing 200–250 g, separately housed in cages
(one rat per cage), with free access to water and
food. The animals were maintained in a room at
23 ± 2°C with a fixed 12-hour artificial light period,
and the air was adequately recycled. All animals were
fed with standard rodent diet with the following
composition (w/w): 20% protein, 3% fat, 2% fibre,
6% minerals, and 69% starch and vitamin supple-
ments (Pasture institute, Iran). All animals received
humane care as outlined in the guide for the care
and use of laboratory animals. The Ethical Commit-
tee of Zahedan University of Medical Sciences ap-
proved this study.
Experimental design
Fifty rats were divided into the five following
groups (n = 10):
(I) Control group (C): rats of this group received
rodent diet and tap water. After one week they
received intraperitoneal vehicle (0.15 M NaCl with
100 mM sodium citrate buffer).
(II) Diabetic group (D): in this group diabetes was
induced by a single intraperitoneal injection of
streptozotocin (60 mg/kg of body weight in 0.15 M
NaCl with 100 mM sodium citrate buffer, pH 4.5).
(III) Treated control group (TC): healthy rats received
eucalyptus supplemented diet and drinking wa-
ter. Eucalyptus was incorporated into the diet
(62.5 g/kg) and drinking water (2.5 g/L) [9].
(IV and V) Treated diabetic groups (TD1, 2): these
groups received, respectively, 20 and 62.5 g/kg
eucalyptus in the diet, and 2.5 g/L AEE in drink-
ing water, from one week after induction of dia-
betes by streptozotocin.
The eucalyptus treatment began one week after
induction of diabetes and lasted for four weeks, and
then the rats were killed. Food and fluid intake of
all groups were measured daily. Body weight and
blood glucose were measured every week.
Glucose measurement
Blood samples were collected from the tail vein.
Blood glucose levels were measured by standard
method of oxidase-peroxidase paired enzyme adapt-
ed for a RA 1000 analyzer (Technicon, USA).
Preparation of tissues
At the end of the experiment, and after overnight
fasting, all animals were sacrificed. The pancreases
were quickly removed, placed in cold saline solution
and trimmed of adipose tissue, and weighed, and
volumes were measured using immersion method
and fixed in modified Lillie’s solution for one week
at room temperature. Using the orientator method,
10–12 isotropic uniform random sections were ob-
tained. Briefly, each pancreas was placed on a circle
that was divided into 36 equal sectors, and was sec-
tioned along the line bearing a randomly selected
number. The sectioned surface of the bar was placed
on the 0–0 direction of the circle with 97 unequal
sinus-weighted divisions and the second cut was
done. After routine histological processing, the new
surface was embedded in paraffin, sectioned (5 µm
thickness) [6, 10, 13], and stained by modified al-
dehyde fuchsin histochemical method [2].
Stereological study
Total number of islets, volume-weighted mean
islet volume, pancreatic islet and beta cell vol-
ume density and total volume
Two sets of primary and reference sections
through the pancreas were sampled using syste-
matic uniform random sampling (SURS) [3, 20].
The total number of islets was determined as
previously described by the so-called physical frac-
tionation method [5, 10] using this formula:
where Nsect (p–p) is the number of sections between
the primary sections, and Nsect (p–r) is the number of sec-
tions between a primary section and the correspond-
ing reference section. DX is the step length in the
x direction, DY is the step length in the y direction, Aframe
is the area of the sampling frame corrected for magni-
fication, and SQisl is the total number of islets counted
(sampled in the primary section but absent in the re-
ference section) from one pancreas [5].
To determine the volume-weighted mean islet
volume, five to seven systematic random fields were
sampled per primary section. At a final magnifica-
tion of 400¥, a grid of standard points and a set of
parallel lines of random orientation were superim-
posed randomly onto the image and the volume-
weighted mean islet volume was estimated using
the point sampled intercepts method [11–13].
Data were entered into a result sheet and the
volume-weighted mean islet volume was estimated
by this formula:
where, Vv is the volume-weighted mean islets vol-
ume, l 3 0
 
 is the mean of the cubed measured inter-
cepts length, and F is:
estNisl = ------------------ ¥ ---------------- ¥ SQisl
Nsect (p–p)
Nsect (p–r)
DX ¥ DY
Aframe
estvv = 
p
 ---
3 
. l 3
 0 . F
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In order to estimate the volume density of islets,
ten to twelve sections were sampled from each gland
by systematic uniform random sampling [13]. A BH2-
-Olympus light microscope with a projecting arm
was used. On each sampled section, five to seven
fields were selected in a systematic random man-
ner. A test system was superimposed on these fields,
and points hitting the various components of the
gland were counted. Then an estimate of the vol-
ume density, Vv, of the components in the refer-
ence space was obtained using:
where P(part) and P(ref) are the number of test points
falling in all structure profiles and in the reference
space, respectively [10, 11, 13].
In order to estimate the absolute volume of
a part, the volume density of that part is multiplied
by the reference volume [13].
Total mass of islets, and pancreas
Total islet mass was determined as previously
described [11–13]. A point-counting grid with
99 points, 1 of them encircled (the unit point), was at-
tached to the table, and for each pancreas the total
number of grid points that hit islets and the total
number of unit points that hit the pancreas were
counted [5]. The total islet mass for each pancreas
was then estimated by:
where Misl is the total islet mass, Pisl is the total num-
ber of grid points that hit islets in all explored sec-
tions from one pancreas, Ptis is the number of unit
points that hit the removed tissue, and Mtis is the
wet weight of it.
The mass of pancreas was estimated using this
formula:
where Ppan is the number of unit points that hit the
pancreatic tissue.
Statistical analysis
Data are presented as the means ± SE for each
investigated parameter. One-way analysis of vari-
ance (ANOVA) followed by Tukey’s post hoc test for
multiple comparisons were used to compare differ-
ences between the experimental groups. The level
of significance was set at p < 0.05. All statistical
analyses were performed using SPSS 11 for Windows
software system.
RESULTS
Effects of eucalyptus treatment on physical
status, blood glucose level, and islet histology
Table 1 shows body weight, food and fluid in-
take, and fasting blood glucose levels in the control
and experimental groups. Diabetic rats showed sig-
nificant (p < 0.001) weight loss and increase of
water and food intake compared with control rats
at the end of the treatment period. Administration
of eucalyptus significantly decreased the weight loss
and water and food intake in eucalyptus treated-
diabetic rats (TD1, 2) compared to untreated-diabe-
tic rats. After STZ injection, the blood glucose levels
of the D and TD1, 2 groups significantly increased
(p < 0.001) in comparison to controls. Treatment of
TD1, 2 rats with eucalyptus extract displayed a signi-
ficant, hypoglycaemic effect in STZ-induced diabetic
rats in comparison to the corresponding D rats. No
significant changes in blood glucose levels were ob-
served after administration of eucalyptus in normally
treated (TC) rats (Table 1).
(---------------------------- )3  [26].magnification
1
estvv = ---------
P(part)
P(ref)
estMisl = -------------------- ¥ Mtis
Pisl
99 ¥ (Ptis)
estMpan = -------- ¥ Mtis
Ppan
Ptis
Table 1. Changes in body weight, food and fluid intake, and serum glucose in experimental groups (n = 10), at the end
of the experiment
Groups C TC D TD1 TD2
Final body weight [g] 335.0 ± 4.1 326.6 ± 6.3 176.4 ± 4.1a 237.6 ± 7.8b 280.2 ± 25.7b
Food intake [g/day] 23.1 ± 0.7 21.8 ± 1.5 59.4 ± 1.1a 33.6 ± 3.2b 27.7 ± 0.6b
Fluid intake [mL/day] 51.2 ± 2.0 54.8 ± 2.7 298.5 ± 3.7a 123.7 ± 5.6b 58.8 ± 8.7b
Serum glucose [mL/dL] 91.1 ± 2.7 87.9 ± 4.2a 281.4 ± 5.5a 203.3 ± 3.2b 117.8 ± 5.3b
The values represent the mean ± SE; C — control; D — diabetic; TC — treated control; TD1,2 — treated diabetic received respectively with 20 g/kg and 62.5 g/kg euca-
lyptus in diet; + 2.5 g/L aqueous extract of eucalyptus in drinking water; ap < 0.001 compared to control group and bp < 0.001 compared to diabetic groups
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Pancreas histological sections in control and
treated control animals possessed normal islets with
clusters of purple granulated beta cells. In diabetic
rats, STZ caused atrophy of the islets and degenera-
tive changes of beta cells. Eucalyptus treatment
partially restored cellular degeneration of beta cells
of islets in treated diabetic rats.
Effects of eucalyptus treatment on
stereological parameters
As indicated in Table 2, diabetes caused a signi-
ficant reduction of pancreatic mass (16.65%), islet
mass, beta cell mass, volume density of islet/pan-
creas, total islet volume, volume density of beta cells/
/islets, total beta cell volume, and volume-weighted
mean islet volume compared to the control group
(p < 0.001). Treatment with eucalyptus compen-
sates these diabetic changes. In the TD1, 2 group, in
comparison with the D group, there was, respec-
tively, a 3.4% and 6.3% increase in pancreatic mass,
which in the TD2 group was statistically significant
(p < 0.05).
In the TD1, 2 groups, compared to the D group,
islet mass increased by 22.9% and 39%, respective-
ly, volume density of islet/ pancreas increased by 12%
and 32%, respectively, total islet volume increased
by 13% and 34%, respectively, and volume-weight-
ed mean islet volume increased by 17% and 22%,
respectively. These parameters in TD2 were statisti-
cally significant from the D group (p < 0.05). Vo-
lume density of beta cells/islets increased 5% and
21%, and total beta cell volume increased 20% and
65% in TD1 and TD2 groups, respectively, but these
differences were not statistically significant from the
D group (p > 0.05). The total number of islets, pan-
creas wet weight, and volume did not show any sig-
nificant changes between these groups (p > 0.05).
DISCUSSION
The present study showed that the treatment of
diabetic rats with Eucalyptus globulus for four weeks
compensated the diabetic state and significantly
reduced blood glucose levels in comparison to the
diabetic rats.
Streptozotocin injection results in diabetes mel-
litus, which may be due to selective destruction of
beta cells [18]. STZ-induced diabetes is character-
ized by weight loss, increase of water and food in-
take, and high blood glucose levels [28]. In treated-
diabetic rats (TD1,2), body weight significantly in-
creased, and water and food intake significantly
decreased, compared to the D group.
In agreement with our results in TC group, Jouad
et al. [16] showed that single and repeated oral ad-
ministration of AEE exhibited a significant, dose-de-
pendent hypoglycaemic effect in STZ diabetic rats.
He also showed that in rats with a normal function-
ing pancreas, no significant changes in blood glu-
cose levels were observed after administration of Eu-
calyptus globulus leaf extract. Ismail [15] showed
that oral administration of AEE in fasted rats exhi-
bited a significant, dose-dependent hypoglycaemic
effect, which represents an effective anti-hypergly-
caemic dietary supplement for the treatment of
Table 2. Pancreas wet weight, mass and volume and stereological parameters of the islets and beta cells in
experimental groups
Parameter C (n = 10) TC (n = 10) D (n = 10) TD1 (n = 10) TD2 (n = 10)
Pancreas wet weight [g] 1.12 ± 0.02 1.11 ± 0.02 1.06 ± 0.02 1.07 ± 0.02 1.07 ± 0.02
Pancreatic mass [mg] 560.5 ± 6.2 551.3 ± 7.6 467.2 ± 6.6a 483.0 ± 8.2a 496.7 ± 6a, b
Pancreas volume [¥ 103 mm3] 2.01 ± 0.03 2.02 ± 0.05 1.95 ± 0.04 1.96 ± 0.05 1.97 ± 0.05
Islets mass [mg] 64.5 ± 1.8 64.6 ± 1.5 24.9 ± 1.5a 30.6 ± 1.6a 34.6 ± 2a, b
Volume density islets/pancreas (%) 28.4 ± 0.8 28.7 ± 1 13.9 ± 0.8a 15.6 ± 1.2a 18.4 ± 1.5b
Total volume of islets [mm3] 572 ± 21 578 ± 16 271 ± 17a 305 ± 25a 363 ± 31a , b
Volume density beta cells/islet (%) 73.2 ± 1.8 72.5 ± 1.5 31.7 ± 2.3a 33.3 ± 1.9a 38.4 ± 2a
Total volume of beta cells [mm3] 41.9 ± 1.9 42.0 ± 1.7 8.5 ± 0.8a 10.2 ± 1.1a 14.0 ± 1.5a
Volume weighted mean islet volume [¥ 106 µm3] 4.11 ± 0.07 4.04 ± 0.1 1.95 ± 0.07a 2.28 ± 0.12a 2.37 ± 0.13a, b
Total islet number [¥ 103] 23.0 ± 1.5 23.2 ± 1.3 21.9 ± 0.8 22.5 ± 0.7 22.7 ± 0.5
Values are mean ± SE; ”n”stands for number of rats in each group. CEs for point counting in each measurement are less than 0.05; C — control; D — diabetic; TC —
treated control; TD1 and TD2 — diabetic rats treated respectively with 20 g/kg and 62.5 g/kg eucalyptus in diet; + 2.5 g/L aqueous extract of eucalyptus in drinking water;
ap < 0.05 compared to control group and bp < 0.05 compared to diabetic groups
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diabetes mellitus. It has been reported that Eucalyp-
tus globulus extract contains high levels of manga-
nese [21]. Manganese chloride can exert a hypogly-
caemic action [9]. Thus the antidiabetic action of this
plant can be attributed, at least in part, to the high
concentration of manganese. Gray and Flatt [9] sug-
gested that eucalyptus probably acted by modulat-
ing insulin secretion and/or insulin action. Another
possibility that they proposed was that eucalyptus
can regenerate beta cells or protect them from STZ-
-induced damage. The present investigation focused
on this view by using stereological methods. Follow-
ing eucalyptus administration, an increase in pancre-
as and islet mass, volume-weighted mean islet vo-
lume, volume density of islets, and total volume of
islets were found in the TD1, 2 groups compared to
the D group. These parameters in the TD2 group were
statistically significant in comparison with the dia-
betic group. This showed a dose-dependent effect of
eucalyptus on pancreatic islets. In this study, the to-
tal number of islets was not significantly different
between the experimental groups. Our previous work
on beta cell protective effects of sodium tungstate
also showed that the number of islets was almost
constant in all groups [12]. Possibly, the architecture
of the islets is complex to the extent that it only al-
lows new islets to be formed during the formation,
growth, or regeneration of the pancreas [4]. The num-
ber of pancreatic islets seems especially to be under
tight genetic control [5], and STZ evokes selective de-
leterious changes in beta cells but it cannot cause com-
plete disappearance of the entire islet [27], thus there
was not any significant reduction in the number of
islets in the D rats. It can be conclude that the in-
crease in total volume of islets in the eucalyptus-treat-
ed rats was caused entirely by islet size due to partial
restoration of beta cells after STZ-induced damage.
Skau et al. [26] reported also that the increase in the
total islet volume during physiological growth in rats
is attributable to islet hypertrophy with no contribu-
tion from islet hyperplasia (increase in the total num-
ber of islets). In the TD2 group, the volume density of
beta cells/islets and total volume of beta cells in-
creased by 21% and 65%, respectively, in compari-
son to the D group. This increase shows a dose-de-
pendent partial recovery of beta cell population. New
beta cells could be derived from intra-islet stem/pro-
genitor cells [26]. Inuwa and El Mardi [14] showed
that the mass of pancreatic islets is dynamic and can
be modified in response to changes in metabolic de-
mand to maintain normoglycaemia. Islet mass de-
pends on, among other factors, the changes in beta
and alpha cell formation, individual cell size, and rate
of cell death. The balance between these elements
determines whether islet mass is increased, remains
stable, or is reduced. In the TD1, 2 groups, the increase
in pancreatic islet mass was probably due to an in-
crease in the mass of its cells, especially beta cells,
because they are the predominant cell type in the
islet, and changes in their biological dynamics are
the most important factors that determine islet mor-
phology [14]. Gray and Flatt [9] indicated that euca-
lyptus is likely act by modulating insulin secretion and/
/or action. Studies using clonal pancreatic beta cells
showed that AEE exerted a dose-dependent stimula-
tory effect on insulin secretion. Jouad et al. [16]
showed that the repeated oral administration of AEE
significantly increased the basal plasma insulin con-
centrations. The levels of insulin were not examined
in our study. However, it seems that partial restora-
tion of pancreatic beta cells, and stimulation of all
functional beta cells following eucalyptus treatment,
could be the reasons for the treatment of the diabe-
tic state of the rats in this study. The second aspect
requires further study. It seems that further investi-
gation with higher doses of eucalyptus, and/or long-
er periods of treatment will be necessary for more
effective results. The chemical nature of the antihy-
perglycaemic constituent(s) of eucalyptus also
remain(s) to be established.
CONCLUSIONS
It can be concluded that eucalyptus in a dose-
-dependent manner could compensate STZ-induced
cell damage of pancreatic beta cells. Thus, it may be
an effective antihyperglycaemic dietary supplement
for the treatment of diabetes and a potential source
for the discovery of new orally active agent(s) for
future diabetes therapy. Further comprehensive
chemical and pharmacological investigations with
isolated active principles of the plant may shed more
light on the use of eucalyptus for antidiabetic acti-
vity in diabetic animals and patients.
ACKNOWLEDGMENTS
The deputy research of Zahedan University of
Medical Sciences supported this study financially. The
authors wish to acknowledge Dr. Harati for his bril-
liant ideas, Dr. F. Heidari for language editing of the
manuscript, and M. Narooei for technical assistance.
REFERENCES
1. Arise RO, Malomo SO, Adebayo JO, Igunnu A (2009)
Effects of aqueous extract of Eucalyptus globulus on
118
Folia Morphol., 2010, Vol. 69, No. 2
lipid peroxidation and selected enzymes of rat liver.
J Med Plants Res, 3: 77–81.
2. Bancroft JD, Gamble M (2002) Theory and practice of
histological technique. 5th Ed. Churchil Livingston, Lon-
don, pp. 556–557.
3. Barbera A, Fernardez-Averez J, Truce A, Gomis R,
Guinovart JJ (1997) Effects of tungstate in neontally strep-
tozotocin-induced diabetic rats: mechanism leading to
normalization of glycemia. Diabetologia, 40: 143–149.
4. Bock T, Kyhnel A, Pakkenberg B, Buschard K (2003) The
postnatal growth of the beta-cell mass in pigs. J Endo-
crinolol, 179: 245–252.
5. Bock T, Pakkenberg B, Buschard K (2005) Genetic back-
ground determines the size and structure of the endo-
crine pancreas. Diabetes, 54: 133–137.
6. Cruz-Orive LM, Weibel ER (1990) Recent stereological
methods for cell biology: a brief survey. Am J Physiol,
258: L148–L156.
7. Duke JH (1985) CRC Handbook of medical herbs. CRC
Press, Boca Raton, Florida, p. 550.
8. Eidi A, Eidi M, Givianrad MH, Abaspour N (2009) Hy-
polipidemic effects of alcoholic extract of eucalyptus
(Eucalyptus globulus Labill.) leaves on diabetic and non-
–diabetic rats. Iran J Diab Lipid Dis, 8: 105–112.
9. Gray AM, Flatt PR (1998) Antihyperglycemic actions of
Eucalyptus globulus (Eucalyptus) are associated with
pancreatic and extra-pancreatic effects in mice. J Nutr,
128: 2319–2323.
10. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N,
Møller A, Nielsen K, Nyengaard. JR, Pakkenberg B,
Sorensen FB, Vesterby A, West MJ (1988) Some new, sim-
ple and efficient stereological methods and their use in
pathological research and diagnosis. APMIS, 96: 379–394.
11. Gundersen HJG, Jensen EB (1985) Stereological esti-
mation of the volume-weighted mean volume of arbi-
trary particles observed on random sections. J Microsc,
138: 127–142.
12. Heidari Z, Mahmoudzadeh-Sagheb HR, Moudi B (2008)
A quantitative study of sodium tungstate protective
effect on pancreatic beta cells in streptozotocin-induced
diabetic rats. Micron, 39: 1300–1305.
13. Howard CV, Reed MG (1998) Unbiased stereology:
three-dimensional measurement in microscopy. 1st Ed.
Biosscientific Publishers, Oxford, pp. 55–68.
14. Inuwa IM, El Mardi AS (2005) Correlation between vo-
lume fraction and volume weighted mean volume, and
between total number and total mass of islets in post-
weaning and young Wistar rats. J Anat, 206: 185–192.
15. Ismail SM (2007) The effect of aqueous extract of the
leaves of eucalyptus globules on the blood glucose level
in fasted rats. Iran J Pharmacol Therap, 6: 185–186.
16. Jouad H, Maghrani M, El Hassani RA, Eddouks M (2004)
Hypoglycemic activity of aqueous extract of Eucalyptus
globulus in normal and streptozotocin-induced diabetic
rats. J Herbs, Spices Med Plants, 10: 19–28.
17. Kang YJ, Jung UJ, Lee MK, Kim HJ, Jeon SM, Park YB,
Chung HG, Baek NI, Lee KT, Jeong TS, Choi MS (2008)
Eupatilin, isolated from Artemisia princeps Pampanini,
enhances hepatic glucose metabolism and pancreatic
beta-cell function in type 2 diabetic mice. Diab Res Clin
Pract, 82: 25–32.
18. Kavalali G, Tuncel H, Göksel S, Hatemi HH (2003) Hy-
poglycemic activity of Urtica pilulifera in streptozoto-
cin-diabetic rats. J Ethnopharmacol, 84: 241–245.
19. Mallick C, Maiti R, Ghosh D (2006) Comparative study
on antihyperglycemic and antihyperlipidemic effects of
separate and composite extract of seed of Eugenia jam-
bolana and root of Musa paradisiaca in Streptozoto-
cin-induced diabetic male albino rat. Iran J Pharmacol
Therap, 5: 27–33.
20. Partida-Hernandez G, Arrola F, Fenton B, Cabeza M,
Roman-Ramos R (2006) Effect of zinc replacement on
lipid and lipoproteins in type 2-diabetic patients.
Biomed Pharmacol, 60: 161–168.
21. Pinto G, Coutinho J, Araujo C, Neves L, Santos C (2007)
Importance of media mineral composition on the in-
duction of somatic embryogenesis in Eucalyptus glo-
bulus labill. Boletin de CIDEU, 3: 83–90.
22. Rao NK, Nammi S (2006) Antidiabetic and renoprotec-
tive effects of the chloroform extract of Terminalia che-
bula Retz seeds in streptozotocin-induced diabetic rats.
BMC Complementary Altern Med, 6: 17.
23. Sabet H (1994) Forests, trees, and shrubs of Iran [In
Persian]. Yazd University Publication, Yazd, Iran, pp.
334–337.
24. Shabeer J, Srivastava RS, Singh SK (2009) Antidiabetic
and antioxidant effect of various fractions of Phyllan-
thus simplex in alloxan diabetic rats. J Ethnopharma-
col, 124: 34–38.
25. Sreemantula S, Kilari EK, Vardhan VA, Rajasekhar
Jaladi R (2005) Influence of antioxidant (L-ascorbic acid)
on tolbutamide induced hypoglycaemia/antihypergly-
caemia in normal and diabetic rats. BMC Endocrine Dis-
orders, 5: 2.
26. Skau M, Pakkenberg B, Buschard K, Bock T (2001) Lin-
ear correlation between the total islet mass and the
volume-weighted mean islet volume. Diabetes, 50:
1763–1770.
27. Takasu N, Asawa T, Komiya I, Nagasawa Y, Yamada T
(1991) Alloxan-induced DNA trend breaks in pancrea-
tic islets. J Biol Chem, 266: 2112–2114.
28. Ugochukwu NH, Babady NE (2003) Antihyperglycemic
effect of aqueous and ethanolic extracts of Gongrone-
ma latifolium leaves on glucose and glycogen metabo-
lism in livers of normal and streptozotocin-induced
diabetic rats. Life Sciences, 73: 1925–1938.
29. Yanardag R, Ozsoy-Sacan O, Bolkent S, Orak H, Karabulut-
-Bulan O (2005) Protective effects of metformin treat-
ment on the liver injury of streptozotocin-diabetic rats.
Human  Experimental Toxicol, 24: 129–135.
